United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2019_register
executive
2019-12-04
article
Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Notices
D09002ee1bdb68d17
D09002ee1bdb68d81
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee. This notice is being published less than 15 days prior to the date of the meeting. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
84 FR 66429
https://www.govinfo.gov/app/details/FR-2019-12-04/2019-26222
2019-26222
fr04de19-56
4164-01-P
Docket No. FDA-2019-N-5119
https://www.govinfo.gov/app/details/FR-2019-12-04/2019-26222
https://www.govinfo.gov/content/pkg/FR-2019-12-04/html/2019-26222.htm
https://www.govinfo.gov/content/pkg/FR-2019-12-04/pdf/2019-26222.pdf
2 p.
66429
66430
84 FR 66429
Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Federal Register Vol. 84, Issue
NOTICE
2019-26222
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2019-12-17
Docket No. FDA-2019-N-5119
4164-01-P
2019-26222
Notice; establishment of a public docket; request for comments.
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee. This notice is being published less than 15 days prior to the date of the meeting. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
The meeting will be held on December 17, 2019, from 8 a.m. to 5 p.m.
Lauren Tesh Hotaki, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, Fax: 301-847-8533, email: ODAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the FDA's website at https://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.
Meetings:
Oncologic Drugs Advisory Committee,
fdaoma@fda.hhs.gov
ODAC@fda.hhs.gov
https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm
https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm
https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm
https://www.fda.gov/AdvisoryCommittees/default.htm
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf
https://www.regulations.gov
Federal Register
Vol. 84, no. 233
Office of the Federal Register, National Archives and Records Administration
2019-12-04
continuing
daily
deposited
born digital
285 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2019-12-04
P0b002ee1a3ea3318
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr04de19
https://www.govinfo.gov/app/details/FR-2019-12-04
https://www.govinfo.gov/content/pkg/FR-2019-12-04/pdf/FR-2019-12-04.pdf
https://www.govinfo.gov/content/pkg/FR-2019-12-04/xml/FR-2019-12-04.xml
fdlp
66281
66559
DGPO
2019-12-04
2023-04-28
FR-2019-12-04
machine generated
eng
FR
FR-2019-12-04
84
233